Post-HCT outcomes for 935 adults with AML undergoing allogeneic HCT while in first or second morphologic remission, stratified by pre- or post-HCT MRD status. Day +100 landmark analysis of (A,C) risk of relapse and (B,D) OS for the entire study cohort, stratified by (A,B) pre-HCT MFC MRD and (C,D) day +70 to +100 post-HCT MFC MRD, respectively.